| Year | Citation |
|---|---|
| 2024 | Apostolopoulos, V., Georgiou, N., Tzeli, D., Mavromoustakos, T., Moore, G. J., Kelaidonis, K., Matsoukas, M. -T., Tsiodras, S., Swiderski, J., & Kate, Gadanec. (240628). Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019.. Bioorg Chem, 150 |
| 2024 |
Moore, G. J., Ridway, H., Gadanec, L. K., Apostolopoulos, V., Zulli, A., Swiderski, J., Kelaidonis, K., Vidali, V. P., Matsoukas, M. T., & Chasapis, C. T. (240601). Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood-Brain Barrier. International Journal of Molecular Sciences, 25(11), doi: 10.3390/ijms25115779 |
| 2024 | Ranasinghe, R., Mathai, M., Abdullah, Alshawsh., & Zulli, A. (240415). Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm. Heliyon, 10(7), |
| 2024 | Gadanec, L. K., McSweeney, K. R., Kubatka, P., Caprnda, M., Gaspar, L., Prosecky, R., Dragasek, J., Kruzliak, P., Apostolopoulos, V., & Zulli, A. (240201). Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms. Molecular and Cellular Biochemistry, 479(2), (233-242). |
| 2024 | Ridgway, H., Moore, G. J., Gadanec, L. K., Zulli, A., Apostolopoulos, V., Hoffmann, W., Wgrzyn, K., Vassilaki, N., Mpekoulis, G., & Zouridakis, M. (240101). Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies. Expert Opinion on Therapeutic Targets, 28(5), (437-459). |
| 2023 | Gadanec, L. K., Swiderski, J., Apostolopoulos, V., Kelaidonis, K., Vidali, V. P., Canko, A., Moore, G. J., Matsoukas, J. M., & Zulli, A. (231201). Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries. International Journal of Molecular Sciences, 24(24), |
| 2023 | McSweeney, K. R., Gadanec, L. K., Kubatka, P., Caprnda, M., Gaspar, L., Prosecky, R., Delev, D., Kruzliak, P., Apostolopoulos, V., & Zulli, A. (231201). Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study. Molecular and Cellular Biochemistry, 478(12), (2907-2916). |
| 2023 |
Gadanec, L. K., Andersson, U., Apostolopoulos, V., & Zulli, A. (230701). Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular Dysfunction. Nutrients, 15(14), doi: 10.3390/nu15143186 |
| 2023 |
Swiderski, J., Sakkal, S., Apostolopoulos, V., Zulli, A., & Gadanec, L. K. (230601). Combination of Taurine and Black Pepper Extract as a Treatment for Cardiovascular and Coronary Artery Diseases. Nutrients, 15(11), doi: 10.3390/nu15112562 |
| 2023 |
Swiderski, J., Gadanec, L. K., Apostolopoulos, V., Moore, G. J., Kelaidonis, K., Matsoukas, J. M., & Zulli, A. (230501). Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019. Biomolecules, 13(5), doi: 10.3390/biom13050787 |
Key details
Areas of expertise
- Cardiovascular & kidney diseases
- Nutrition and dietary therapy in chronic diseases prevention and treatment
- Examining the role of the Mas receptor in endothelial dysfunction
- Cancer
Available to supervise research students
Available for media queries
About Anthony Zulli
Dr Zulli joined Victoria University after finishing his NHMRC Peter Doherty Fellowship in 2009 (2006-2009, University of Melbourne, Austin Health). Dr Zulli's research focuses on the mechanisms that cardiovascular disease risk factors (homocysteine/cholesterol) cause endothelial dysfunction. His research has an emphasis on the nitric oxide pathway, oxidative stress and the renin-angiotensin system, and has a recent interest on reducing kidney disease caused by cancer treatments. Dr Zulli has been funded by the National Heart Foundation and NHMRC, as well as internal VU grant schemes. His pharmacology laboratory is equipped with 80 organ bath units, were he studies blood vessels from the microvasculature (60 micron diameter) to large conduit arteries (2-4mm diameter). His approved research utilises rabbits, rats, guinea pigs and mice.
His work has recently shown that the cardiovascular risk factor homocysteine could affect the efficacy of antioxidant therapy, and his collaborative work has shown that hormones released from bone can 'talk' to blood vessels during stress, improving their function.
He has published over 80 manuscripts, attracted over $1 million in funds and collaborates with local, national and international scientists.
Qualifications
- PhD, University of Melbourne, 2009
- GCTE, Victoria University
Key publications
Anthony has over 127 publications, with a selection listed here.
A more comprehensive list of Anthony's publications is available in the VU Research Repository.
Journal article (showing 10 of 123)
Research funding for the past 5 years
Please note:
- Funding is ordered by the year the project commenced and may continue over several years.
- Funding amounts for contact research are not disclosed to maintain commercial confidentiality.
- The order of investigators is not indicative of the role they played in the research project.
2017
|
The role of osteocalcin in blood vessel disease: A novel approach to fight blood vessels disease.
From: Rebecca L Cooper Medical Research Foundation Limited
Other investigators: Prof Itamar Levinger
For period: 2017-2018
|
$24,900 |
Supervision of research students at VU
Available to supervise research students
Available for media queries
Currently supervised research students at VU
| No. of students | Study level | Role |
|---|---|---|
| 1 | PhD | Principal supervisor |
| 1 | PhD | Associate supervisor |
Currently supervised research students at VU
| Students & level | Role |
|---|---|
| PhD (1) | Principal supervisor |
| PhD (1) | Associate supervisor |
Completed supervision of research students at VU
| No. of students | Study level | Role |
|---|---|---|
| 2 | PhD | Associate supervisor |
| 2 | PhD | Principal supervisor |
| 1 | Masters by Research | Associate supervisor |
Completed supervision of research students at VU
| Students & level | Role |
|---|---|
| PhD (2) | Associate supervisor |
| PhD (2) | Principal supervisor |
| Masters by Research (1) | Associate supervisor |
Teaching activities & experience
Unit Coordinator for RBM3800: Pharmacology
Keynote and invited speeches
| Year | Title/Description |
|---|---|
| 2019 |
Lifestyle and coronary artery disease Ausmed Education: The Nurse Health Coach Conference (28-29 October) |
| 2019 |
Coronary artery disease and homocysteine Ausmed Education: Chronic Disease Conference (9-10 September) |
Professional memberships
- Secretary, Australian Vascular Biology Society
- Academic Member, Australian Atherosclerosis Society
